期刊文献+

IL-21——一种新的免疫系统调节因子 被引量:7

Interleukin 21, a new immune regulator
原文传递
导出
摘要 IL-21是于2000年发现的属于IL-2细胞因子家族的新成员。它同该家族其它成员(IL-2、IL-4、IL-7、IL-9、IL-13和IL-15)共用一个受体亚单位γc。IL-21由活化的CD4^+T辅助细胞产生的,其受体表达在多种免疫细胞(B、T、NK细胞)上,因此对多种免疫细胞有重要的生物调节作用。IL-21能提高B淋巴细胞的增殖,提高IgG1的产生,抑制IgE的产生,从而调节人体体液免疫。IL-21还可增强NK细胞、T淋巴细胞的增殖与杀伤功能,从而增强人体的细胞免疫。作为最新的免疫系统调节因子,IL-21在免疫调节、抗肿瘤中的作用越来越受到研究者的重视,已成为该领域的研究热点。 Interleukin 21 ( IL-21 ) , a member of Interleukin 2 (IL-2) cytokine family, was discovered in 2000. It shares a common subunit of γc with the other members (such as IL-2,IL-4,IL-7, IL-9,IL-13 and IL-15 ) of the IL-2 cytokine family. IL-21 is produced by activated CD4 positive cells, and its receptor is expressed on many immune cells, such as B lymphocytes, T lymphocytes and NK cells. Therefore, IL-21 has an important regulated effect on the immune cells. It can promote the proliferation of B lymphocytes, enhance the producti6n of IgG1, inhibit the production of IgE, and regulate the cellular immunity. In addition, IL-21 can also promote the proliferation and enhance the function of both NK cells and T lymphocytes. Therefore, IL-21 regulates humoral immunity. As an immune regular, IL-21 plays an important role in the immne regulation and anti-tumor immunotherapy, and has gained a great deal of interest in the related researches.
作者 赵明峰
出处 《国际免疫学杂志》 CAS 2008年第5期360-364,共5页 International Journal of Immunology
基金 天津市卫生局科技基金(05KY10)和教育部留学归国人员科研启动基金(教外司留[2007]1108号)
关键词 IL-21 IL-21受体 免疫调节 抗肿瘤 IL-21 IL-21R Immune regulation Anti-tumor
  • 相关文献

参考文献28

  • 1Parrish-Novak J, Dillon SR, Nelson A, et al. Interleukin 21 and its receptor are involved in NK cell expansion and regulation of lymphocyte function. Nature, 2000, 408 (6808) :57-63.
  • 2许晓群,张建(审校者).白细胞介素21免疫学效应研究进展[J].国际免疫学杂志,2006,29(1):34-37. 被引量:3
  • 3Habib T, Senadheera S, Weinberg K, et al. The common gamma chain (gamma c) is a required signaling component of the IL-21 receptor and supports IL-21-induced cell proliferation via JAK3. Biochemistry, 2002, 41 (27) :8725-8731.
  • 4Brandt K, Bulfone-Paus S, Foster DC, et al. Interleukin-21 inhibits dendritic cell activation and maturation. Blood, 2003, 102 (12) :4090-4098.
  • 5Gowda A, Roda J, Hussain SR, et al. IL-21 mediates apoptosis through up-regulation of the BH3 family member BIM and enhances both direct and antibody-dependent cellular cytotoxicity in primary chronic lymphocytic leukemia cells in vitro. Blood, 2008, 111(9) :4723-4730.
  • 6Scheeren FA, Diehl SA, Smit LA, IL-21 is expressed in Hodgkin lymphoma and activates STAT5: evidence that activated STAT5 is required for Hodgkin lymphomagenesis. Blood, 2008, 111 (9) : 4706-15.
  • 7Coquet JM, Kypafissoudis K, Pellicci DG, el al, IL-21 is produced by NKT cells and modulales NKT cell activation and cytokine production. J Immunol, 2007,178 (5) :2827-2834.
  • 8Strengell M, Matikainen S, Siren J, et al. IL-21 in synergy with IL-15 or IL-18 enhances IFN-gamma production in human NK and T cells. J Immunol, 2003,170( 11 ) :5464-5469.
  • 9Zeng R, Spolski R, Casas E, et al. The molecular basis of IL-21- mediated proliferation. Blood, 2007,109(10) :4135-4142.
  • 10Good KL, Bryant VL, Tangye SG. Kinetics of human B cell behavior and amplification of proliferative responses following stimulation with IL-21. J Immunol, 2006,177 (8) :5236-5247.

二级参考文献20

  • 1Parrish-Novak J, DiUon SR, Nelson A, et al. Interleukin 21 and its receptor are involved in NK cell expansion and regulation of lymphocyte function.Nature,2000,408(1):57-63.
  • 2Warster AL, Rodgers VL, Satoskar AR, et al. Interleukin 21 is a T helper(Th) cell 2 cytokine that specifically inhibits the differentiation of naive Th cells into interferon gamma-producing Th1 cells. J Exp Med, 2002, 196(7) :969-977.
  • 3Shan B, Yu L, Shimozato O, et al. Expression of interleukin-21 and -23 in human esophageal tumors produced antitumor effects in nude mice. Anticancer Res, 2004,24(1):79-82.
  • 4Mehta DS, Wurster AL, Whitters MJ, et al. IL-21 induces the apoptosis of resting and activated primary B cells. J Immunol, 2003, 170(8):4111-4118.
  • 5Brenne AT, Baade Ro T, Waage A, et al. Interleukin-21 is a growth and survival factor for human myeloma cells. Blood,2002,99(10) : 3756-3762.
  • 6Koizumi T, Wang J, Suzuki Y, et al. Regulation of bcl-xL expression and Fas susceptibility in mouse B cells by CD40 ligation, surface IgM crosslinking and IL-4. Mol Immunol, 1996,33(16) : 1247-1253.
  • 7Manna SK, Haridas V, Aggarwal BB. Bcl-x(L) suppresses TNF-mediated apoptosis and activation of nuclear factor-kappaB, activation protein- 1, and c-Jun N-terminal kinase. J Interferon Cytokine Res, 2000, 20 ( 8 ) : 725-735.
  • 8Pene J, Gauchat JF, Lecart S, et al. IL-21 is a switch factor for the production of IgG1 and IgG3 by human B cells.J Immunol,2004,172(9) :5154-5157.
  • 9Suto A, Nakajima H, Hirose K, et al. Interleukin 21 prevents antigen-induced IgE production by inhibiting germ line C (epsilon) transcription of IL-4-stimulated B cells. Blood,2002,100(13) :4565-4573.
  • 10Hecker M, Bohnert A, Konig IR, et al. Novel genetic variation of human interleukin-21 receptor is associated with elevated IgE levels in females.Genes Immun,2003,4(3) :228-233.

共引文献2

同被引文献86

引证文献7

二级引证文献31

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部